GlobeNewswire
-
VivoSim Labs to Showcase Breakthrough Multiparametric NAMkind™ Liver and Intestine Data at the 2026 American College of Toxicology (ACT) Annual Meeting
16/11/2026 -
XORTX Completes Manufacturing of Clinical Drug Supply
16/11/2026 -
HCW Biologics Reports Third Quarter 2026 Business and Clinical Development Highlights and Financial Results
16/11/2026 -
Novo Nordisk A/S - share repurchase programme
16/11/2026 -
SCIENTURE Reports Q3 2026 Results with Approximately 265% Sequential Revenue Growth Driven by the Commercial Launch of REZENOPY™
16/11/2026 -
Nuo Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update
16/11/2026 -
Prenetics’ IM8 Announces Three-Time GRAMMY-Winning DJ and Producer Diplo as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
16/11/2026 -
MindBio Achieves Significant Product Development Milestone with up to 83% Accuracy in Intoxication Detection Using Voice Analytics and AI; Announces Private Placement
16/11/2026 -
Microbot Medical® Files 10-Q and Highlights Key Third Quarter Operating Achievements
16/11/2026 -
Corxel US Presents Full Phase 2 Results for CX11 in Adults with Overweight and Obesity at ObesityWeek® 2026
16/11/2026 -
Ziphius, a leading saRNA biotech, today announces the appointment of Mr. Antoon Loomans to its Board of Directors
16/11/2026 -
Omada Health Presents AI-Powered Meal Feedback Research and 12-Month GLP-1 Care Track Outcomes at ObesityWeek 2026
16/11/2026 -
Diakonos Oncology Presents DOC1021 Data Showing Encouraging Survival Signal in Newly Diagnosed Glioblastoma at SNO 2026
16/11/2026 -
HealthEdge Introduces AI Strategy to Protect Health Plans From Unpredictable AI Costs
16/11/2026 -
Four students, one shared goal: a healthier Saskatchewan
16/11/2026 -
Vaso Corporation Announces Financial Results for Third Quarter of 2026
16/11/2026 -
Tris Pharma Named a BioSpace 2027 Best Places to Work Winner
16/11/2026 -
Precision Neuroscience and Team Gleason Partner to Give the ALS Community a Voice in Brain–Computer Interface Development
16/11/2026 -
VIVUS Announces Preferred Formulary Status for PANCREAZE® Across Major National Medicare Formulary
16/11/2026
Pages